Principal Street Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.21M Sell
20,496
-246
-1% -$87.7K 1.18% 34
2025
Q4
$6.79M Sell
20,742
-501
-2% -$159K 1.15% 29
2025
Q3
$5.99M Sell
21,243
-1,904
-8% -$552K 0.96% 44
2025
Q2
$6.46M Buy
23,147
+2,349
+11% +$665K 0.63% 42
2025
Q1
$6.48M Buy
20,798
+1,363
+7% +$402K 1.21% 24
2024
Q4
$5.07M Buy
19,435
+340
+2% +$101K 1% 41
2024
Q3
$6.15M Sell
19,095
-5,353
-22% -$1.75M 1.01% 31
2024
Q2
$7.64M Buy
24,448
+1,437
+6% +$422K 1.37% 17
2024
Q1
$6.7M Buy
23,011
+5,387
+31% +$1.58M 1.27% 38
2023
Q4
$5.08M Sell
17,624
-3,577
-17% -$975K 1.22% 31
2023
Q3
$5.7M Buy
21,201
+896
+4% +$224K 1.13% 14
2023
Q2
$4.51M Sell
20,305
-791
-4% -$184K 1.07% 40
2023
Q1
$5.1M Sell
21,096
-80
-0.4% -$19.6K 1.29% 35
2022
Q4
$5.56M Sell
21,176
-261
-1% -$70K 1.4% 28
2022
Q3
$4.83M Sell
21,437
-3,504
-14% -$849K 1.29% 22
2022
Q2
$6.07M Sell
24,941
-304
-1% -$74.5K 1.57% 13
2022
Q1
$6.1M Buy
25,245
+5,272
+26% +$1.21M 1.4% 19
2021
Q4
$4.49M Sell
19,973
-1,379
-6% -$291K 1.08% 43
2021
Q3
$4.54M Buy
21,352
+2,336
+12% +$538K 1.24% 37
2021
Q2
$4.63M Sell
19,016
-34,423
-64% -$8.47M 1.22% 35
2021
Q1
$13.3M Buy
53,439
+36,200
+210% +$8.64M 1.72% 24
2020
Q4
$3.96M Sell
17,239
-1,196
-6% -$276K 1.21% 38
2020
Q3
$4.68M Sell
18,435
-1,739
-9% -$431K 1.65% 17
2020
Q2
$4.76M Sell
20,174
-8,973
-31% -$2.05M 1.78% 13
2020
Q1
$5.91M Buy
29,147
+27,775
+2,024% +$6.07M 2.48% 5
2019
Q4
$331K Buy
1,372
+16
+1% +$3.53K 0.07% 157
2019
Q3
$262K Buy
+1,356
New +$260K 0.07% 159

Other funds holding AMGN

Principal Street Partners's AMGN Position: Q1 2026 in Review

Principal Street Partners reduced its Amgen (AMGN) stake by 1.2% in Q1 2026, selling an estimated $87.7K and leaving 20,496 shares worth $7.21M. The position accounts for 1.18% of the portfolio, ranked #34.

Principal Street Partners first reported a position in AMGN in Q3 2019 and has held it in 27 quarters since. The position peaked at $13.3M in Q1 2021. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Principal Street Partners held 20,496 shares of Amgen worth $7.21M as of Q1 2026.
  • Principal Street Partners sold 246 Amgen shares in Q1 2026, an estimated $87.7K.
  • Amgen made up 1.18% of Principal Street Partners's portfolio in Q1 2026, its #34 holding.
  • Principal Street Partners first reported a position in Amgen in Q3 2019 and has held it in 27 quarters since.
  • Principal Street Partners's Amgen position peaked at $13.3M in Q1 2021.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Principal Street Partners's 13F filing for Q1 2026, filed 15 May 2026.